SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a new rapid diagnostic testing tool to detect respiratory syncytial virus (RSV) in professional healthcare settings.
The OSOM RSV Test is a rapid immunochromatographic assay for the qualitative detection of RSV nucleoprotein antigen in anterior nasal swab specimens from patients with signs and symptoms of respiratory infections in just 15 minutes. It is CLIA-waived for use at the point of care and like most of the other OSOM Rapid Tests, it is made in the USA and supported by a highly skilled technical support team of medical technologists/professionals.
Unlike most rapid RSV antigen tests, the OSOM test is uniquely designed to serve a broader patient demographic that targets two high-risk groups for severe RSV infection. The test is cleared for use for children aged six months to six-years old and adults aged 60 and older, providing healthcare professionals with a better diagnostic tool for these patient populations.
"With the overlapping symptoms of common respiratory infections and the disparate treatment protocols for each, it is more critical than ever to provide accurate and timely results. Now that there are different treatment options on the market, we found it extremely important to expand our respiratory portfolio to provide healthcare professionals diagnostic solutions to improve the health of their patients." said Harold Chan, VP & General Manager Point-of-Care Business Unit.
SEKISUI Diagnostics is a well-known provider of many rapid diagnostic solutions to the professional and home testing markets through a portfolio of tests under the OSOM, Metrix and Acucy brands.